Lack of internal toxicologists, uncertainty about when and how to test, and the costs of in vivo methods, especially when animal use and veterinary oversight are involved, can delay approval and inflate budgets. That’s why more organisations are turning to in vitro alternatives. Validated, reproducible, and reliable, these methods often offer improved predictability for human response. They also support faster decision-making, clearer regulatory pathways, and a more ethical approach to product development.

At Eurofins Medical Device Services network of laboratories, our in vitro biocompatibility testing services are fully aligned with ISO 10993-1. You will have access to a team of scientific experts and toxicologists committed to evaluating safety efficiently, ethically, and accurately. We are committed to the 3Rs principles of Replacement, Reduction, and Refinement in animal testing, by offering robust alternatives that meet global regulatory expectations.

Our testing for:

• Local tolerance testing using reconstructed human epithelium
• Performance testing such as barrier efficacy, wound healing, and whitening tests
• Surface modification analysis including osteoblast and fibroblast proliferation

Our compliant in vitro laboratory in Europe houses some of the most advanced technology in the industry. We support both standardised testing and custom assay development, partnering with clients to select the most suitable method for their materials and applications. We also collaborate closely with regulatory agencies, ensuring all studies meet the latest requirements.